Literature DB >> 29722092

Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.

S Kim1, Y M Yoon2, Y-S Han2, J H Lee3, J Hur4, S H Lee2,5.   

Abstract

OBJECTIVES: The purpose of this study was to explore the effectiveness of concurrent GRP78 overexpression combined with Cripto on hMSC proliferation and migration both in vitro and in vivo. Specifically, we explored whether the treatment enhances effectiveness of hMSC transplantation in ischaemic tissue.
MATERIALS AND METHODS: Human MSCs obtained from human adipose tissue were cultured in α-minimum essential medium (Hyclone, Logan, UT, USA) supplemented with 10% (v/v) foetal bovine serum (Hyclone), 100 U mL-1 penicillin and 100 μg mL-1 streptomycin. Murine hindlimb ischaemic model was generated with 8-week-old male nude BALB/c mice (Biogenomics, Seoul, Korea) maintained under a 12-h light/dark cycle following the established protocol with minor modification. Cellular injection was performed no later than 3 hour after surgery. Lipofectamine transfection, single-cell cultivation assay, transwell assay, scratch wound-healing migration assay, immunohistochemistry and western blotting assays were performed.
RESULTS: Overexpression of GRP78 along with Cripto enhanced hMSC proliferation, migration and invasion. It increased interaction of surface GRP78 receptor with Cripto via JAK2/STAT3 pathway. We confirmed our proposed mechanism by showing that treatment with GRP78 antibody blocks the enhancement in vitro. In vivo, we observed that Cripto induced by the hypoxic environment in hindlimb ischaemic model interacts with the overexpressed GRP78 and increases hMSC proliferation, migration and invasion potentials as well as angiogenesis around transplanted ischaemic site via cytokine secretions.
CONCLUSIONS: These results demonstrate supporting evidences that GRP78-Cripto combination technique offers novel strategy to enhance MSC proliferation, migration and invasion potentials as well as angiogenesis around ischaemic site, ultimately facilitating MSC-based transplantation therapy in ischaemic conditions.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cripto; GRP78; angiogenesis; cell proliferation; invasion; mesenchymal stem cells

Mesh:

Substances:

Year:  2018        PMID: 29722092      PMCID: PMC6528945          DOI: 10.1111/cpr.12463

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  35 in total

Review 1.  A trip to the ER: coping with stress.

Authors:  D Thomas Rutkowski; Randal J Kaufman
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

2.  Overexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-β/Smad2/3 signaling.

Authors:  Lichao Zhang; Zongwei Li; Yongsheng Fan; Hanqing Li; Zhouyu Li; Yaoping Li
Journal:  Int J Biochem Cell Biol       Date:  2015-04-28       Impact factor: 5.085

3.  Stat3 promotes directional cell migration by regulating Rac1 activity via its activator betaPIX.

Authors:  Terk Shin Teng; Baohong Lin; Ed Manser; Dominic Chi Hiung Ng; Xinmin Cao
Journal:  J Cell Sci       Date:  2009-10-27       Impact factor: 5.285

4.  Setting limits.

Authors:  R de Tornyay
Journal:  J Nurs Educ       Date:  1990-03       Impact factor: 1.726

Review 5.  Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.

Authors:  Gabriella Minchiotti
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

6.  Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.

Authors:  Hironori Nakagami; Kazuhisa Maeda; Ryuichi Morishita; Sota Iguchi; Tomoyuki Nishikawa; Yoichi Takami; Yasushi Kikuchi; Yukihiro Saito; Katsuto Tamai; Toshio Ogihara; Yasufumi Kaneda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-13       Impact factor: 8.311

7.  GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Authors:  Gidi Shani; Wolfgang H Fischer; Nicholas J Justice; Jonathan A Kelber; Wylie Vale; Peter C Gray
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

8.  Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture.

Authors:  Lei Wang; Yi Li; Jieli Chen; Subhash C Gautam; Zhenggang Zhang; Mei Lu; Michael Chopp
Journal:  Exp Hematol       Date:  2002-07       Impact factor: 3.084

9.  Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.

Authors:  J A Kelber; A D Panopoulos; G Shani; E C Booker; J C Belmonte; W W Vale; P C Gray
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

10.  Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration.

Authors:  Carolina Prezioso; Salvatore Iaconis; Gennaro Andolfi; Lorena Zentilin; Francescopaolo Iavarone; Ombretta Guardiola; Gabriella Minchiotti
Journal:  Front Cell Dev Biol       Date:  2015-05-21
View more
  4 in total

1.  Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.

Authors:  S Kim; Y M Yoon; Y-S Han; J H Lee; J Hur; S H Lee
Journal:  Cell Prolif       Date:  2018-05-02       Impact factor: 6.831

2.  MiR-138-1-3p alters the stemness and radiosensitivity of tumor cells by targeting CRIPTO and the JAK2/STAT3 pathway in nasopharyngeal carcinoma.

Authors:  Tao Du; Jiahui Jiang; Yiting Chen; Nengwei Zhang; Guanyang Chen; Xingwei Wang; Xueying Long; Xueping Feng
Journal:  Ann Transl Med       Date:  2021-03

Review 3.  Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.

Authors:  Seung J Baek; Bruce D Hammock; In-Koo Hwang; Qingxiao Li; Naima Moustaid-Moussa; Yeonhwa Park; Stephen Safe; Nanjoo Suh; Sun-Shin Yi; Darryl C Zeldin; Qixin Zhong; Jennifer Alyce Bradbury; Matthew L Edin; Joan P Graves; Hyo-Young Jung; Young-Hyun Jung; Mi-Bo Kim; Woosuk Kim; Jaehak Lee; Hong Li; Jong-Seok Moon; Ik-Dong Yoo; Yiren Yue; Ji-Young Lee; Ho-Jae Han
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

Review 4.  Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?

Authors:  Patricia Rieken Macêdo Rocco; Bruno Solano de Freitas Souza; Kátia Nunes da Silva; André Luiz Nunes Gobatto; Zaquer Suzana Munhoz Costa-Ferro; Bruno Raphael Ribeiro Cavalcante; Alex Cleber Improta Caria; Luciana Souza de Aragão França; Carolina Kymie Vasques Nonaka; Fernanda de Macêdo Lima; Miquéias Lopes-Pacheco
Journal:  Stem Cell Res Ther       Date:  2021-07-27       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.